NANOMETRICS INC
10-Q/A, 1999-02-16
MEASURING & CONTROLLING DEVICES, NEC
Previous: NANOMETRICS INC, 10-Q/A, 1999-02-16
Next: NANOMETRICS INC, 10-Q/A, 1999-02-16





                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                   FORM 10-Q/A

_X_  Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange
     Act of 1934

For the quarterly period ended June 30, 1998

     Transition  report  pursuant  to  Section  13 or  15(d)  of the  Securities
     Exchange Act of 1934

For the transition period from _______________ to _______________

Commission file number          0-13470
                       ----------------------------


                            NANOMETRICS INCORPORATED
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)


          California                                       94-2276314
- -------------------------------                       ------------------
(State or other jurisdiction of                       (I. R. S. Employer
 incorporation or organization)                       Identification No.)


   310 DeGuigne Drive, Sunnyvale, CA                         94086
- ----------------------------------------                  ----------
(Address of principal executive offices)                  (Zip Code)


Registrant's telephone number, including area code (408) 746-1600
                                                   ------------------

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed  by  Section  13 or 15 (d) of the  Securities  Exchange  Act of 1934
during the preceding 12 months (or for such shorter  period that the  registrant
was  required  to file such  reports),  and (2) has been  subject to such filing
requirements for the past 90 days.

                                YES _X_   NO ___


At July 14,  1998 there were  8,663,998  shares of common  stock,  no par value,
issued and outstanding.

                                       1

<PAGE>


                            NANOMETRICS INCORPORATED

                                   Form 10-Q/A

This Amendment on Form 10-Q/A amends the  Registrant's  Quarterly Report on Form
10-Q,  as filed by the  Registrant  on August 11,  1998,  and is being  filed to
reflect the restatement of the Registrant's  Consolidated  Financial Statements.
See Note 2 to the Notes to Consolidated Financial Statements for a discussion of
the basis for such restatement.


                                      INDEX

Part I.  Financial Information                                              Page
                                                                            ----

     Item 1.   Financial Statements

               Consolidated Balance Sheets -
               June 30, 1998 (as restated) and December 31, 1997 ..........  3

               Consolidated Statements of Income -
               Three months and six months  ended
               June 30, 1998 (as restated) and 1997 .......................  4

               Consolidated  Statements  of Cash Flows
               Six months ended June 30, 1998 (as restated)
               and 1997 ...................................................  5

               Notes to Consolidated Financial
               Statements .................................................  6


     Item 2.   Management's Discussion and Analysis of
               Financial Condition and Results of Operations .............. 10



Part II.  Other Information

     Item 4.   Submission of Matters to a Vote of Security Holders ........ 14

     Item 6.   Exhibits and Reports on Form 8-K ........................... 14

Signatures ................................................................ 15

                                       2

<PAGE>


PART I:      FINANCIAL INFORMATION
ITEM 1:      FINANCIAL STATEMENTS

<TABLE>
                                                      NANOMETRICS INCORPORATED
                                                     CONSOLIDATED BALANCE SHEETS
                                             (Amounts in thousands except share amounts)
                                                             (Unaudited)

<CAPTION>
                                                                                                  June 30,              December 31,
                                                                                                    1998                     1997
                                                                                                   --------                --------
                                                                                               (As Restated)*
<S>                                                                                                <C>                     <C>
ASSETS

CURRENT ASSETS:
   Cash and equivalents                                                                            $    933                $  3,656
   Short-term investments                                                                             9,872                   9,595
   Accounts receivable, less allowance for
     doubtful accounts of $410 and $413                                                              11,379                  10,225
   Inventories                                                                                       10,746                   7,138
   Deferred income taxes                                                                              1,881                   2,094
   Prepaid expenses and other                                                                           760                   1,075
                                                                                                   --------                --------

                  Total current assets                                                               35,571                  33,783

PROPERTY, PLANT AND EQUIPMENT, NET                                                                    2,112                   2,187

OTHER ASSETS                                                                                          1,682                     273
                                                                                                   --------                --------

TOTAL                                                                                              $ 39,365                $ 36,243
                                                                                                   ========                ========

LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
   Accounts payable                                                                                $  2,062                $  1,889
   Accrued payroll and related expenses                                                                 618                     596
   Other current liabilities                                                                          2,447                   1,493
   Income taxes payable                                                                                 359                     565
   Current portion of long-term debt                                                                    600                     604
                                                                                                   --------                --------

                  Total current liabilities                                                           6,086                   5,147

LONG-TERM DEBT                                                                                        2,185                   2,568
                                                                                                   --------                --------

                  Total liabilities                                                                   8,271                   7,715
                                                                                                   --------                --------

SHAREHOLDERS' EQUITY:
   Common stock, no par value; 25,000,000 shares
     authorized; 8,663,998 and 8,521,484 outstanding                                                 13,726                  13,151
   Retained earnings                                                                                 18,263                  16,144
   Accumulated translation adjustment                                                                  (895)                   (767)
                                                                                                   --------                --------
                  Total shareholders' equity                                                         31,094                  28,528
                                                                                                   --------                --------

TOTAL                                                                                              $ 39,365                $ 36,243
                                                                                                   ========                ========

<FN>
*See Note 2 to Consolidated Financial Statements

See Notes to Consolidated Financial Statements
</FN>
</TABLE>

                                                                 3

<PAGE>


<TABLE>
                                                      NANOMETRICS INCORPORATED
                                                  CONSOLIDATED STATEMENTS OF INCOME
                                          (Amounts in thousands, except per share amounts)
                                                             (Unaudited)

<CAPTION>
                                                                         Three Months Ended                 Six Months Ended
                                                                             June 30,                            June 30,
                                                                    1998               1997              1998                1997
                                                                  --------           --------           --------           --------
                                                               (As Restated)*                        (As Restated)*
<S>                                                               <C>                <C>                <C>                <C>
NET REVENUES:
   Product sales                                                  $  9,705           $  7,741           $ 19,323           $ 15,042
   Service                                                           1,023                958              1,943              1,916
                                                                  --------           --------           --------           --------

   Total net revenues                                               10,728              8,699             21,266             16,958
                                                                  --------           --------           --------           --------

COSTS AND EXPENSES:
   Cost of product sales                                             4,029              2,902              7,658              5,639
   Cost of service                                                     967                874              1,952              1,737
   Research and development                                          1,063                665              2,294              1,339
   Acquired in-process research and
     development                                                      --                 --                1,421               --
   Selling                                                           1,529              1,626              3,101              2,889
   General and administrative                                          694                613              1,479              1,249
                                                                  --------           --------           --------           --------

   Total costs and expenses                                          8,282              6,680             17,905             12,853
                                                                  --------           --------           --------           --------

OPERATING INCOME                                                     2,446              2,019              3,361              4,105

OTHER INCOME (EXPENSE):
   Interest income                                                     156                126                317                241
   Interest expense                                                    (20)               (24)               (46)               (49)
   Other, net                                                         (139)                 5               (148)                (6)
                                                                  --------           --------           --------           --------
   Total other income (expense), net                                    (3)               107                123                186
                                                                  --------           --------           --------           --------

INCOME  BEFORE PROVISION
 FOR  INCOME TAXES                                                   2,443              2,126              3,484              4,291

PROVISION FOR INCOME TAXES                                             948                753              1,365              1,644
                                                                  --------           --------           --------           --------

NET INCOME                                                        $  1,495           $  1,373           $  2,119           $  2,647
                                                                  ========           ========           ========           ========

NET INCOME PER SHARE:
   Basic                                                          $    .17           $    .17           $    .25           $    .32
                                                                  ========           ========           ========           ========
   Diluted                                                        $    .17           $    .16           $    .24           $    .31
                                                                  ========           ========           ========           ========

SHARES USED IN PER SHARE
COMPUTATION:
   Basic                                                             8,641              8,282              8,593              8,282
                                                                  ========           ========           ========           ========
   Diluted                                                           9,003              8,665              8,991              8,669
                                                                  ========           ========           ========           ========

<FN>
* See Note 2 to the Notes to Consolidated Financial Statements

See Notes to Consolidated Financial Statements
</FN>
</TABLE>

                                                                 4

<PAGE>


<TABLE>
                                                      NANOMETRICS INCORPORATED
                                                CONSOLIDATED STATEMENTS OF CASH FLOWS
                                                       (Amounts in thousands)
                                                             (Unaudited)

<CAPTION>
                                                                                                             Six Months Ended
                                                                                                                  June 30,
                                                                                                          1998               1997
                                                                                                         --------          --------
                                                                                                     (As Restated)*
<S>                                                                                                      <C>               <C>     
CASH FLOWS FROM OPERATING ACTIVITIES:
   Net income                                                                                            $  2,119          $  2,646
   Adjustments to reconcile net income to net
    cash provided by operating activities:
   Depreciation and amortization                                                                              119               148
   Purchase of in-process technology                                                                        1,421              --
   Deferred taxes                                                                                            (656)              (58)
   Changes in assets and liabilities net of effects of product line acquisition:
       Accounts receivable                                                                                   (830)            2,227
       Other receivables                                                                                       (3)             (135)
       Inventories                                                                                         (2,081)           (1,208)
       Prepaid expenses and other                                                                             255              (354)
       Accounts payable and other liabilities                                                                 265               506
       Income taxes payable                                                                                  (101)           (1,272)
                                                                                                         --------          --------

Net cash provided by (used in) operating activities                                                           508             2,500
                                                                                                         --------          --------

CASH FLOWS FROM INVESTING ACTIVITIES:
   Purchase of short-term investments                                                                     (11,126)          (12,590)
   Sales/maturities of short-term investments                                                              10,849            10,608
   Capital expenditures                                                                                      (123)              (81)
   Product line acquisition                                                                                (3,038)             --
                                                                                                         --------          --------

Net cash used in investing activities                                                                      (3,438)           (2,063)
                                                                                                         --------          --------

CASH FLOWS FROM FINANCING ACTIVITIES:
   Repayments of long-term debt                                                                              (204)             (167)
   Issuance of common stock                                                                                   575               157
                                                                                                         --------          --------

Net cash provided by financing activities                                                                     371               (10)
                                                                                                         --------          --------

EFFECT OF EXCHANGE RATE CHANGES ON CASH                                                                      (164)              611
                                                                                                         --------          --------

NET CHANGE IN CASH AND EQUIVALENTS                                                                         (2,723)            1,038
CASH AND EQUIVALENTS, beginning of period                                                                   3,656             1,725
                                                                                                         --------          --------

CASH AND EQUIVALENTS, end of period                                                                      $    933          $  2,763
                                                                                                         ========          ========

SUPPLEMENTAL DISCLOSURE OF CASH FLOW
INFORMATION:
   Cash paid for interest                                                                                $     49          $     49
                                                                                                         ========          ========

   Cash paid for income taxes                                                                            $  2,122          $  3,679
                                                                                                         ========          ========

<FN>
* See Note 2 to the Notes to Consolidated Financial Statements

See Notes to Consolidated Financial Statements
</FN>
</TABLE>

                                                                 5

<PAGE>


                            NANOMETRICS INCORPORATED
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                   (Unaudited)

Note 1 Consolidated Financial Statements

         The  consolidated   financial   statements   include  the  accounts  of
Nanometrics  Incorporated  and its wholly owned  subsidiaries.  All  significant
inter-company accounts and transactions have been eliminated.

         While the quarterly financial  statements are unaudited,  the financial
statements  included in this report reflect all adjustments  (consisting only of
normal recurring  adjustments) which the Company considers  necessary for a fair
presentation of the results of operations for the interim periods covered and of
the financial condition of the Company at the date of the interim balance sheet.
The operating results for interim periods are not necessarily  indicative of the
operating  results  that may be expected for the entire  year.  The  information
included  in this  report  should be read in  conjunction  with the  information
included  in the  Company's  1997  Annual  Report  on Form 10-K  filed  with the
Securities and Exchange Commission.

Note 2. Restatement of Quarterly Financial Statements

         Subsequent to the issuance of the Company's June 30, 1998  consolidated
financial statements,  the Securities and Exchange Commission ("the SEC") issued
new  guidance  on  its  views  regarding  the  valuation   methodology  used  in
determining acquired in-process research and development expensed on the date of
acquisition.  As a result of the new  guidance,  the  Company has  modified  its
methods used to value the acquired in-process research and development and other
intangible  assets  acquired in connection  with the Optical  Specialties,  Inc.
("OSI") product line  acquisition (see Note 4 below).  The revised  valuation is
based on management estimates of the after-tax net cash flows and gives explicit
consideration to the SEC's views on acquired in-process research and development
as set forth in its  September  9,  1998  letter to the  American  Institute  of
Certified Public Accountants.  As a result of the revised valuation,  the amount
of purchase price  allocated to in-process  research and  development  decreased
from  $2,036,000  to  $1,421,000,  and the amount  ascribed to other  intangible
assets increased from $0 to $615,000.

<TABLE>
         The consolidated  financial  statements as of June 30, 1998 and for the
three  months  and six  months  then  ended  have  been  restated  from  amounts
previously  reported  to  reflect  the  revised  valuation  of  assets  acquired
including  goodwill,  core and developed  technology and in-process research and
development.  The  effects of such  restatement  are  summarized  as follows (in
thousands, except per share amounts):

<CAPTION>
                                                                             Three Months Ended                Six Months Ended
                                                                               June 30, 1998                     June 30, 1998
                                                                           -----------------------           -----------------------
                                                                       As Previously                     As Previously
                                                                         Reported        As Restated        Reported     As Restated
                                                                         --------        -----------        --------     -----------
<S>                                                                        <C>              <C>              <C>           <C>   
Cost of product sales                                                      $3,998           $4,029           $7,627        $7,658

Acquired in-process research and development                               $ --             $ --             $2,036        $1,421

Operating income                                                           $2,477           $2,446           $2,777        $3,361

Income before provision for income taxes                                   $2,474           $2,443           $2,900        $3,484

Provision for income taxes                                                 $  960           $  948           $1,131        $1,365

Net income                                                                 $1,514           $1,495           $1,769        $2,119

Basic net income per share                                                 $  .18           $  .17           $  .21        $  .25

Diluted net income per share                                               $  .17           $  .17           $  .20        $  .24
</TABLE>

                                                                  6

<PAGE>


                                                    At June 30, 1998
                                       ----------------------------------------
                                       As Previously Reported       As Restated
                                       ----------------------       -----------
Deferred income taxes                         $ 2,115                 $ 1,881

Other assets                                  $ 1,098                 $ 1,682

Retained earnings                             $17,913                 $18,263

Total shareholders' equity                    $30,744                 $31,094


Note 3. Inventories

         Inventories  are stated at the lower of cost  (first-in,  first-out) or
market and consist of the following (in thousands):

                                                       June 30,     December 31,
                                                         1998           1997
                                                       -------         -------
Raw materials and subassemblies                        $ 6,667         $ 2,934
Work in process                                          2,428           1,528
Finished goods                                           1,651           2,676
                                                       -------         -------
                                                       $10,746         $ 7,138
                                                       =======         =======


Note 4. Product Line Acquisition

         On March 30, 1998 the Company  entered  into an  agreement  with OSI to
purchase a metrology  system product line and related assets used to measure the
critical  dimensions  and overlay  registration  errors  observed  in  submicron
lithography. Under the agreement, the Company paid approximately $3.2 million in
cash (of which $187,000 was accrued and remained unpaid as of June 30, 1998) for
the assets and in-process research and development. The total purchase price and
final  allocation  among the  tangible  and  intangible  assets and  liabilities
acquired  (including acquired in-process research and development) is summarized
as follows (in thousands):

Total Purchase Price:
      Total cash consideration                                          $ 3,225
                                                                        =======

Purchase Price Allocation:
      Tangible assets                                                   $ 1,923
      Intangible assets:
         Core and developed technology                                      419
         Goodwill                                                           196
      In-process research and development                                 1,421
      Tangible liabilities                                                 (734)
                                                                        -------
                                                                        $ 3,225
                                                                        =======


         The  intangible   assets  are  recorded  within  other  assets  in  the
accompanying  consolidated  balance  sheet  as of June 30,  1998  and are  being
amortized over a five year useful life.

         The valuation was based on management's  estimates of the after tax net
cash  flows  and gave  explicit  consideration  to the SEC's  views on  acquired
in-process research and development as set forth in its September 9, 1998 letter
to the American  Institute of Certified Public  Accountants.  Specifically,  the
valuation  gave  consideration  to the  following:  (i) the employment of a fair
market value premise  excluding any  Nanometrics-specific  considerations  which
would result in estimates of investment  value for the subject  assets and; (ii)
comprehensive due diligence concerning all potential intangible assets including
trademarks/tradenames,  patents, copyrights,  non-compete agreements,  assembled
workforce  and  customer  relationships  and  sales  channel.  The value of core
technology was explicitly  addressed,  with a view toward  ensuring the relative
allocations  to core  technology and in-process  research and  development  were
consistent  with the relative  contributions  of each to the final product.  The
allocation to  in-process  research and  development  was

                                       7

<PAGE>


based on a  calculation  that  considered  only the efforts  completed as of the
transaction  date, and only the cash flow associated with said completed efforts
for the product currently in process.

         As noted above, the Company recorded a one-time charge of $1,421,000 in
the first  quarter of 1998 for  acquired  in-process  research  and  development
related to a development project that had not reached technological feasibility,
had  no  alternative  future  use  and  for  which  successful  development  was
uncertain.  The  conclusions  that the  in-process  development  effort,  or any
material   sub-component,   had  no  alternative   future  use  was  reached  in
consultation with engineering personnel from both Nanometrics and OSI.

         The project to complete the Metra 7000 product  includes the completion
of a software  platform  design  started by OSI in 1997.  As of the  acquisition
date, the Metra 7000 had yet to achieve  technological  feasibility  since there
was not a working prototype with a reliable new software  platform.  At the time
of the  acquisition,  the  estimated  cost to complete this software and related
development was approximately $300,000. The Company began shipments of the Metra
7000 product to a customer in June 1998 and it was at that time that the Company
began to benefit from the  acquired  research  and  development  related to this
product.

         Significant  assumptions  used to  determine  the  value of  in-process
research and development included several factors,  including the following: (i)
forecast of net cash flows that were  expected  to result  from the  development
effort,  using  projections  prepared  by  Nanometrics'  management;   and  (ii)
percentage  complete of 77% for the Metra  project  estimated by  considering  a
number of factors, including the costs invested to date relative to the expected
total cost of the development  effort and the amount of progress completed as of
the  acquisition  date,  on a  technological  basis,  relative  to  the  overall
technological achievements required to achieve the intended functionality of the
eventual  product.  The  technological  issues  were  addressed  by  engineering
representatives  from both Nanometrics and OSI; and when estimating the value of
the  technology,  the projected  financial  results of the acquired  assets were
estimated on a stand-alone basis without any consideration to potential synergic
benefits or "investment value" related to the acquisition. Accordingly, separate
projected  cash  flows  were  prepared  for  both  the  existing  as well as the
in-process Metra 7000 products. These projected results were based on the number
of units sold times  average  selling  price less the  associated  costs.  After
preparing the estimated cash flow from the product being developed, a portion of
this cash flow was attributed to the core  technology,  which is embodied in the
in-process Metra 7000 product line and enables the development of the Metra 7000
quicker and more cost  effectively.  When estimating the value of the developed,
core  and  in-process   technologies,   discount  rates  of  25%,  30%  and  35%
respectively,  were used. These discount rates consider both the status and risk
associated with the respective cash flows as of the acquisition date.

         In addition,  during the three months ended March 31, 1998, the Company
hired certain  former  employees of OSI and incurred  approximately  $350,000 in
related,  non-recurring  hiring  expenses  (such  expenses are classified in the
accompanying  consolidated  statement  of  income  according  to the  employees'
function).

Note 5. Other Current Liabilities

         Other current liabilities consist of the following (in thousands):

                                           June 30, 1998      December 31, 1997
                                           -------------      -----------------
Commissions payable                           $  528                $  564
Accrued warranty                               1,026                   479
Other                                            893                   450
                                              ------                ------
                                              $2,447                $1,493
                                              ======                ======

                                       8

<PAGE>


Note 6. Net Income Per Share

       The reconciliation of the share denominator used in the basic and diluted
net income per share computations are as follows (in thousands):

                                             Three Months Ended Six Months Ended
                                                   June 30         June 30
                                                1998    1997    1998     1997
                                                -----   -----   -----   -----
Weighted average common shares
  outstanding-shares used in basic
  net income per share computation              8,641   8,282   8,593   8,282
Dilutive effect of common stock equivalents,
  using the treasury stock method                 362     383     398     387
                                                -----   -----   -----   -----
Shares used in dilutive net income
  per share computation                         9,003   8,665   8,991   8,669
                                                =====   =====   =====   =====


         During the three and six month  periods  ended June 30,  1998 and 1997,
the Company had common stock options  outstanding which could potentially dilute
basic net income per share in the future, but were excluded from the computation
of diluted net income per share as the common  stock  options'  exercise  prices
were greater than the average  market price of the common shares for the period.
At June 30,  1998,  380,500 such common  stock  options with a weighted  average
exercise price of $10.20 per share were excluded from the diluted net income per
share computations.

Note 7. Comprehensive Income

         In the  first  quarter  of  1998,  the  Company  adopted  Statement  of
Financial Accounting Standard No. 130, "Reporting  Comprehensive  Income," which
requires an enterprise to report the change in net assets during the period from
nonowner sources  ("comprehensive  income"). For the three months ended June 30,
1998 and 1997,  comprehensive  income,  which  consisted  of net  income for the
periods and changes in accumulated translation  adjustments,  was $1,401,000 and
$1,584,000,  respectively.  For the six  months  ended  June 30,  1998 and 1997,
comprehensive income was $1,991,000 and $2,678,000, respectively.

Note 8. Recently Issued Accounting Standard

         In June 1997, the Financial  Accounting Standards Board issued SFAS No.
131, "Disclosure about Segments of an Enterprise and Related Information," which
establishes annual and interim reporting standards for an enterprise's  business
segments and related disclosures about its products, services,  geographic areas
and major  customers.  This  statement  is  effective  for fiscal  year 1998 and
adoption will not affect the Company's financial position, results of operations
or cashflows.

Note 9. New Accounting Pronouncements

         In June 1998, the Financial  Accounting Standards Board issued SFAS No.
133,  "Accounting  for Derivative  Instruments  and Hedging  Activities,"  which
defines derivatives, requires that all derivatives be carried at fair value, and
provides for hedging  accounting when certain conditions are met. This statement
is effective for all fiscal  quarters of fiscal years  beginning  after June 15,
1999.  Although the Company has not fully assessed the  implications of this new
statement,  the Company does not believe  adoption of this statement will have a
material impact on the Company's financial position or results of operations.

                                       9

<PAGE>


ITEM 2. MANAGEMENT'S  DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        OF OPERATIONS

Product Line Acquisition

         On March 30, 1998,  the Company  entered into an agreement with Optical
Specialties,  Inc.  ("OSI") to  purchase a  metrology  system  product  line and
related  assets to measure the  critical  dimensions  and  overlay  registration
errors  observed in  submicron  lithography.  Subsequent  to the issuance of the
Company's June 30, 1998 consolidated  financial  statements,  the Securities and
Exchange  Commission  ("the SEC") issued new guidance on its views regarding the
valuation  methodology  used in  determining  acquired  in-process  research and
development  expensed  on the  date  of  acquisition.  As a  result  of the  new
guidance,  the  Company has  modified  its  methods  used to value the  acquired
in-process  technology and other  intangible  assets acquired in connection with
the OSI product line acquisition.  The revised valuation was based on management
estimates of the after tax net cash flows and gave explicit consideration to the
SEC's views on acquired  in-process research and development as set forth in its
September  9,  1998  letter  to  the  American  Institute  of  Certified  Public
Accountants.  As a result of the revised valuation, the amount of purchase price
allocated to in-process  research and  development  decreased from $2,036,000 to
$1,421,000 and the amount ascribed to other intangible  assets increased from $0
to $615,000.  Accordingly,  the Company's  Consolidated Financial Statements and
Management  Discussion  and  Analysis  of  Financial  Condition  and  Results of
Operations have been restated to reflect such  adjustments  described herein and
in Note 2 to the Notes to Consolidated Financial Statements.

Results of Operations

         Total  net  revenues  for the three  months  ended  June 30,  1998 were
$10,728,000,  an increase of  $2,029,000  or 23% from the  comparable  period in
1997.  For the six months ended June 30,  1998,  total  revenues of  $21,266,000
increased by $4,308,000 or 25% from the comparable period in 1997. Product sales
of $9,705,000 and $19,323,000 for the three months and six months ended June 30,
1998,  respectively,   increased  $1,964,000  or  25%  and  $4,281,000  or  28%,
respectively,  as compared with the same periods  during 1997.  The increases in
product sales resulted from stronger demand for, and increased shipments of, the
Company's products, especially its automated products, particularly to customers
in the Far East and Europe.  In addition,  sales of the recently  acquired Metra
product  contributed  $1,400,000  to  revenues  in the  second  quarter of 1998.
Service revenue of $1,023,000 and $1,943,000 for the three months and six months
ended June 30, 1998,  respectively,  increased  $65,000 or 7% and $27,000 or 1%,
respectively,  as  compared  to the same  periods in 1997.  These  increases  in
service revenue are primarily attributable to higher sales of accessories in the
U.S.

         Cost of product sales as a percentage of product sales increased to 42%
in the  second  quarter  of 1998  from  37% in the  second  quarter  of 1997 and
increased  to 40% in the six months  ended  June 30,  1998 from 37% for the same
period in 1997  primarily  because of Metra sales which had a lower gross margin
than the Company's other products and underabsorbed  manufacturing costs related
to the start up of production  on the Metra  product line.  Cost of service as a
percentage  of service  revenue  increased to 95% in the second  quarter of 1998
from 91% in the second  quarter of 1997 and  increased to 100% in the six months
ended  June 30,  1998  from 91% for the same  period  in 1997 as a result of the
increased cost of additional  headcount  associated with servicing the Company's
new Metra product line.

         Research  and  development  expenses  for the three month and six month
periods  ended June 30,  1998  increased  $398,000  or 60% and  $955,000  or 71%
respectively,  compared  to the  same  periods  in  1997  due  primarily  to the
increased cost of additional  headcount associated with research and development
for the Company's new Metra product line.

                                       10

<PAGE>


         In the first  quarter of 1998,  the  Company  paid  approximately  $3.2
million for the assets and in-process  research and development related to OSI's
Metra product line. Of this purchase price,  $1,421,000  related to the value of
in-process  technology  that had no  alternative  future use and was  charged to
expense in the accompanying  consolidated statement of income for the six months
ended June 30, 1998.

         Selling  expenses in the second quarter of 1998 decreased by $97,000 or
6% compared to the second quarter of 1997 when the mix of products sold included
more  sales  by  outside  sales   representatives   which   resulted  in  higher
commissions.  Selling  expenses for the six months ended June 30, 1998 increased
$212,000  or 7% compared  to the same  period in 1997  primarily  because of the
increased cost of additional  headcount  associated with the sales and marketing
of the Company's new Metra product line.

         General and  administrative  expenses for the three month and six month
periods  ended June 30, 1998  increased  by $81,000 or 13% and  $230,000 or 18%,
respectively,  compared  to the same  periods in 1997  primarily  as a result of
spending associated with the increased level of operations.

         Other income  (expense),  net for the three month and six month periods
ended June 30, 1998 decreased  $110,000 or 103% and $63,000 or 34% respectively,
from the comparable  periods in 1997 due primarily to royalty costs and exchange
rate losses.

         The Company  reported an operating  income of $2,446,000 and net income
of $1,495,000 for the second quarter of 1998 compared to an operating  income of
$2,019,000  and net income of  $1,373,000  for the same period in 1997.  For the
first six months of 1998, the Company reported an operating income of $3,361,000
and net income of $2,119,000 which compared to an operating income of $4,105,000
and net income of $2,647,000 for the same period in 1997.

Liquidity and Capital Resources

         At June 30,  1998,  the  Company  had  working  capital of  $29,485,000
compared to $28,636,000 at December 31, 1997. The current ratio at June 30, 1998
was 5.8 to 1. The Company believes working capital including cash and short-term
investments of $10,805,000 will be sufficient to meet its needs at least through
the next twelve  months.  Operating  activities for the first six months of 1998
provided cash of $508,000  primarily from net income adjusted for the in-process
technology purchase of the Metra product line which was offset to some extent by
increased  accounts  receivable  and  inventory,  while  the  net  purchases  of
short-term  investments  used  $277,000,  capital  expenditures  used  $123,000,
purchase of the Metra product line used $3,038,000, debt repayment used $204,000
and issuance of common stock provided $575,000.

Recently Issued Accounting Standard

         In June 1997, the Financial  Accounting Standards Board issued SFAS No.
131,  "Disclosures  about  Segments of an Enterprise  and Related  Information,"
which  establishes  annual and interim  reporting  standards for an enterprise's
business  segments  and  related  disclosures  about  its  products,   services,
geographic  areas and major  customers.  This  statement is effective for fiscal
year 1998 and adoption will not affect the Company's financial position, results
of operations or cashflows.

Year 2000 Issues

Many computer systems are expected to experience  problems handling dates around
the year 2000 ("Y2K").  The Y2K issue is the result of many currently  installed
computer  programs being written using

                                       11

<PAGE>


two digits rather than four to define the  applicable  year. As a result,  these
computer programs are unable to distinguish  between 21st century dates and 20th
century dates and could cause computer system failures or  miscalculations  that
result in significant business disruptions.  Described below are the actions the
Company  has  taken,  and  plans to take,  to  address  the  potential  problems
resulting as systems attempt to handle dates around the millennium.

State of Readiness The Company's upper  management has discussed and agreed upon
a  comprehensive  plan to address  its Y2K  issues.  The Y2K plan  includes  the
following activities:  gathering data and taking inventory;  testing systems and
products to evaluate Y2K compliance;  execution of remediation activities to fix
non-compliant  products and systems;  and  monitoring  and testing  products and
systems on an ongoing basis. The major business areas impacted are:

     Products:  Many of the Company's products  incorporate computer software to
     control certain add-on features and  functionality.  The Company's products
     are measurement tools and Y2K issues arise in the Company's  products where
     database functions are used (e.g. storage of measurement data). The Company
     has completed testing and evaluation of its products for Y2K compliance. As
     a result of such  evaluation,  the Company  believes  that: (i) most of its
     current  product  lines are Y2K  compliant;  (ii)  upgrades  are  currently
     available or will be available by mid-1999 for non-Y2K compliant  automated
     products;  and (iii) as database functionality is not used in certain older
     obsolete  products and in  non-automated  systems,  Y2K  compliance  is not
     believed to be an issue.

     Procurement:  Critical suppliers have been contacted and status of products
     and internal  systems have been verified.  The Company is in the process of
     evaluating the balance of its supplier base. This evaluation is expected to
     be completed by March 31, 1999.

     Manufacturing:  The Company's  assembly and test equipment is scheduled for
     ongoing  upgrades to Y2K compliant  configurations  through  mid-1999.  The
     Company's primary manufacturing application software system is scheduled to
     be upgraded to be Y2K  compliant by  mid-1999.  The cost of such upgrade is
     included in the estimate of the costs to upgrade the information technology
     as discussed below.

     Information  Technology  Systems ("IT"): The Company has conducted a survey
     of its IT  hardware  and  software  and has  identified  substantially  all
     non-Y2K  compliant  hardware and software.  The Company has purchased a Y2K
     upgrade  license from its IT vendor and expects to implement the upgrade by
     mid-1999.  The Company currently  estimates the cost of the upgrade license
     and the related  internal and external costs to implement will  approximate
     $140,000.

     Facilities and Infrastructure:  An assessment of the Y2K readiness of owned
     and leased assets has been performed and systems which will require upgrade
     or  replacement  include the security and card key system and the voicemail
     system.

Costs While the  Company  has not yet  completed  the entire  evaluation  of the
required  activities to address the Y2K issues,  the Company currently  believes
that the  estimated  costs of Y2K  compliance  efforts  are not  expected  to be
material to the Company.

Risks The Company  believes the most reasonably  likely worst case Y2K scenarios
include the following:

Customers  could  change their  buying  patterns in a number of ways,  including
accelerating or delaying purchases of, or replacement of, the Company's products
and services.

The Company  could  experience  a  disruption  in service to its  customers as a
result of the failure of third party  products,  including the following:  third
party products which are  non-compliant  and are

                                       12

<PAGE>


incorporated  into the  Company's  products  could cause the products to fail; a
breakdown in telephone,  e-mail,  voicemail,  could impact the responsiveness of
the  Company's  customer  service  department;  Y2K  problems at a number of the
Company's suppliers  including banks,  telephone companies and the United States
Postal  Service  could have a pervasive  impact on the  Company's  business as a
whole;  and  product  features  that  rely on date  parameters  (generally  date
dependent routings and operating reports) could malfunction.

Although the Company's products are undergoing both Y2K specific, and its normal
testing procedures,  its products may not contain all of the necessary date code
or other  changes to operate in the year 2000.  Any failure of such  products to
perform could result in: claims and lawsuits against the Company;  significantly
impaired customer  satisfaction  resulting in customers withholding cash owed to
the Company and delaying or  canceling  orders;  and  managerial  and  technical
resources  being  diverted  away from  product  development  and other  business
activities.

Any of the above  stated  consequences,  in addition to others which the Company
cannot yet foresee,  could have a  significant  adverse  impact on the Company's
business, operating results and financial condition.

Contingency  Plan The Company  currently  believes  that its plan is adequate to
address its Y2K issues,  and accordingly,  does not believe that it is practical
to  develop  a  comprehensive  contingency  plan.  Based on the  current  plan's
timeline,  the  Company  believes  that  it  would  be  able  to  determine  the
effectiveness  of the current plan by mid-1999.  As such,  in the event that its
current  plan is not  adequate to address the Y2K issues,  the Company  believes
that there will be adequate time to establish and implement a contingency  plan.
Once a contingency plan is implemented,  however,  the Company cannot be certain
that such a plan would prevent  significant  Y2K problems from having a material
adverse  effect on the  Company's  business,  operating  results  and  financial
condition.

Forward Looking Statements

         The  foregoing  Management's   Discussion  and  Analysis  of  Financial
Condition and Results of Operations contains  forward-looking  statements within
the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the
Securities   Exchange  Act  of  1934.   These   statements   involve  risks  and
uncertainties and actual results could differ materially as a result of a number
of factors  including  demand for the company's  products,  which is affected by
factors including the cyclicality of the semiconductor,  magnetic recording head
and flat panel  display  industries  served by the Company,  patterns of capital
spending  by  customers,  technological  changes  in the  markets  served by the
Company and its customers, market acceptance of products of both the Company and
its  customers,  the  timing,  cancellation  of delay  of  customer  orders  and
shipments,  competition,  including  competitive  pressure on product prices and
changes in pricing by the  Company's  customers  or  suppliers,  fluctuation  in
foreign currency exchange rates particularly the Japanese yen, the proportion of
direct sales versus  sales  through  distributors  and  representatives,  market
acceptance of new and enhanced versions of the Company's products, the timing of
new  product  announcements  and  releases  of  products  by the  Company or its
competitors,   including  the  Company's   ability  to  design,   introduce  and
manufacture  new  products on a timely and cost  effective  basis,  the size and
timing  acquisitions of business,  products or technologies  and fluctuations in
the  availability and cost of components and  subassemblies  and the factors set
forth under  "Management's  Discussion  and Analysis of Financial  Condition and
Results of Operations - Risk Factors" in the 1997 Annual  Report.  on form 10-K.
The Company  undertakes no obligation to update forward looking  statements made
in this report to reflect events or circumstances  after the date of this report
or to update reasons why actual  results could differ from those  anticipated in
such forward-looking statements.

                                       13

<PAGE>


                            NANOMETRICS INCORPORATED
                                     PART II

                                OTHER INFORMATION

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

A. The annual meeting of shareholders was held on June 18, 1998.

B. The following directors were elected to the board of directors:

             Vincent J. Coates
             Nathaniel Brenner
             Norman V. Coates
             John D. Heaton
             Clifford F. Smedley
             Kanegi Nagai

<TABLE>
C. The following matters were voted upon at the annual meeting:

<CAPTION>
                                                       For              Against         Abstain
                                                       ---              -------         -------
1.       To elect the following directors
         to serve for the ensuing year:
<S>                                                  <C>                   <C>           <C>   
         Vincent J. Coates, Chairman                 7,318,208             0              3,500
         Nathaniel Brenner, Director                 7,320,208             0              1,500
         Norman V. Coates, Director                  7,305,008             0             16,700
         John D. Heaton, Director                    7,318,167             0              3,541
         Clifford F. Smedley, Director               7,320,208             0              1,500
         Kanegi Nagai, Director                      7,320,208             0              1,500


2.       To ratify the appointment of
         Deloitte & Touche LLP as independent
         auditors for the fiscal year ending
         December 31, 1998.                          7,319,438             0              2,270
</TABLE>


ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

A.       Exhibits

         Ex. 27 -  Financial Data Schedule

B.       Reports on Form 8-K.

         None.

                                       14

<PAGE>


                            NANOMETRICS INCORPORATED

                                    SIGNATURE

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned thereunto duly authorized.

NANOMETRICS INCORPORATED
(Registrant)



/s/ Vincent J. Coates
- -----------------------------
Vincent J. Coates
Chairman of the Board



/s/ John Heaton
- -----------------------------
John Heaton
Chief Executive Officer



/s/ Paul B. Nolan
- -----------------------------
Paul B. Nolan
Chief Financial Officer


Dated:    February 16, 1999

                                       15


<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                                   1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              Dec-31-1998
<PERIOD-START>                                 Jan-01-1998
<PERIOD-END>                                   Jun-30-1998
<CASH>                                             933
<SECURITIES>                                     9,872
<RECEIVABLES>                                   11,789
<ALLOWANCES>                                       410
<INVENTORY>                                     10,746
<CURRENT-ASSETS>                                35,571
<PP&E>                                           5,115
<DEPRECIATION>                                   3,003
<TOTAL-ASSETS>                                  39,365
<CURRENT-LIABILITIES>                            6,086
<BONDS>                                          2,185
                                0
                                          0
<COMMON>                                        13,726
<OTHER-SE>                                      17,368
<TOTAL-LIABILITY-AND-EQUITY>                    39,365
<SALES>                                         19,323
<TOTAL-REVENUES>                                21,266
<CGS>                                            7,658
<TOTAL-COSTS>                                    9,610
<OTHER-EXPENSES>                                 8,295
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  46
<INCOME-PRETAX>                                  3,484
<INCOME-TAX>                                     1,365
<INCOME-CONTINUING>                              2,119
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,119
<EPS-PRIMARY>                                      .25
<EPS-DILUTED>                                      .24
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission